H8 - No, not in this case. This is a very unusual set of conditions where you have a drug (assuming FDA approval) that will take away what I call the "death factor" rendering Covid19 as nothing more than the flu - and that's not just here in the US but all over the world. Couple that with upcoming potential approvals for HIV (combo and mono), NASH, tNBC + various other cancers, etc and you have a company about to explode onto the scene, much to the dismay of big pharma.